Investor Presentaiton

Countries Maxigesic roll out continues across the world TARGETED MAXIGESIC FY 2022-2023 Maxigesic countries sold and ordered* 90 80 70 60 50 40 30 20 10 28 20 7 9 3 4 43 53 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 84 FY 2022 progress to date: • Tablets: Launched in Switzerland, Greece and Lithuania • • Maxigesic IV: launched in Germany and Austria Oral Liquid: Registered in Italy and Malta. Product Maxigesic Tablets Maxigesic IV Maxigesic Oral Solution Territories 31 Oct 2021 31 March 2021 31 Oct 2021 31 March 2021 31 Oct 2021 31 March 2021 Licensed 100+ 100+ 100+ 100+ 100+ 100+ Registered 51 49 29 21 2 0 3 Sold in 46 43 50 3 0 0 AFTpharmaceuticals Page 11

View entire presentation